🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a randomized, double-blind, placebo-controlled, multicentre, phase...
Status
Completed
Location
Central Alabama Research
Start Date
2020-01-22
Trial ID
NCT04196101
A Non-Randomized, Open-Label, Two-Part, Drug-Drug Interaction Study to Eval...
Status
Completed
Location
Pharmaceutical Research Associates, Inc.,
Start Date
2018-11-02
Trial ID
NCT03750383
Treatments Being Tested
This was a Phase 2b, randomized, double-blind, placebo-controlled, multicen...
Status
Terminated
Location
Augusta University Medical Center
Start Date
2021-07-07
Trial ID
NCT04633187
A 2-part study to evaluate the safety, pharmacokinetics and efficacy of EDP...
Status
Completed
Location
Memorial Care Miller Children's and Women's Hospital
Start Date
2022-04-26
Trial ID
NCT04816721
This was a Phase 2b, randomized, double-blind, placebo-controlled study of ...
Status
Completed
Location
Voyage Medical
Start Date
2022-11-29
Trial ID
NCT05568706
This randomized, double-blind, placebo-controlled study will assess the saf...
Status
Completed
Location
Pharmaceutical Research Associates, Inc.,
Start Date
2017-12-07
Trial ID
NCT03384823
A Non-Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the E...
Status
Completed
Location
Pharmaceutical Research Associates, Inc.,
Start Date
2021-03-12
Trial ID
NCT04871724
Treatments Being Tested
A randomised, Phase 2a, double-blind, placebo-controlled study to evaluate ...
Status
Completed
Location
hVIVO Services Limited (hVIVO)
Start Date
2018-10-15
Trial ID
NCT03691623
Treatments Being Tested
A Non-Randomized, Open-Label, Three-Part, Drug-Drug Interaction Study to Ev...
Status
Completed
Location
Pharmaceutical Research Associates, Inc.,
Start Date
2018-11-29
Trial ID
NCT03755778
The purpose of the study is to assess the effect of a therapeutic and supra...
Status
Completed
Location
ICON
Start Date
2024-07-15
Trial ID
NCT06601192
Treatments Being Tested